Navigation Links
QSV Biologics awarded cGMP manufacturing contract by Pfizer Inc.
Date:5/1/2008

stomer Value Enhancement Award" in 2005 and the BioAlberta "Company of the Year Award" in 2007. QSV's global clientele spans 3 continents and develops protein therapeutics, vaccines & diagnostics. As a dedicated CMO with no competing products of its own, QSV builds value for its clients by producing quality products in a timely manner. Hence its acronym: QSV: Quality & Speed build Value.


'/>"/>
SOURCE QSV Biologics, Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Specialists Are Turning to Biologics Earlier in the Treatment of Psoriasis and Psoriatic Arthritis
2. Nabi Biopharmaceuticals Announces Sale of Nabi Biologics to Biotest AG
3. AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune
4. Biotest Pharmaceuticals Corporation Completes Acquisition of Nabi Biologics Business Unit
5. Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant
6. Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine
7. MedImmune Submits Biologics License Application to FDA for Motavizumab
8. Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
9. Study by Leading Economist Identifies Potential for $378 Billion of Savings From Follow On Biologics
10. Biologics, Derma Fillers are Key to Dermatological Drug Market Growth
11. Insmed Selected to Complete Congressional Questionnaire Regarding the Potential Establishment of a Follow-On Biologics Regulatory Pathway
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... May 21, 2013 Alpha Source, ... , will be exhibiting for the 13th consecutive ... Medical Instrumentation (AAMI) 2013 Conference and Expo. The ... distribute, and manufacture healthcare technologies. This year’s event ... Beach, California. , The three-day event draws ...
(Date:5/21/2013)... York , May 21, 2013 ... Transparency Market Research ( http://www.transparencymarketresearch.com ) "Biochip Products and ... IVD Tests) - U.S. Industry Analysis, Size, Share, Growth, Trends and ... billion in 2011 and is expected to grow at ... reach an estimated value of USD 4.7 billion in ...
(Date:5/21/2013)... Md. , May 21, 2013  Synthetic Biologics, Inc. ... prevention and treatment of serious infectious diseases, announced today that ... the 2 nd Annual Marcum LLP MicroCap Conference on ... at the Grand Hyatt Hotel. Mr. Riley is ... A live webcast of Synthetic Biologics, presentation can be accessed ...
(Date:5/21/2013)... Ontario (PRWEB) May 21, 2013 ... scientists of the ITN to design the study, ... of two key clinical models used in the ... (EEC) and Nasal Allergen Challenge (NAC) models. Although ... by numerous publications, to date no direct comparison ...
Breaking Biology Technology:Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference 2Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2
... MADISON, Wis., July 29 James C. Powell, ... has joined the,Board of Directors of Nerites Corporation., ... coatings,and consummated dozens of corporate partnerships to commercialize ... of Coatings Product,Development; he helped lead the company,s ...
... Volcano Corporation,(Nasdaq: VOLC ), a leading ... (FM) and Optical Coherence,Tomography (OCT) products designed to ... vascular disease, today announced that it will,report its ... six months of,fiscal 2008 on Tuesday, August 5., ...
... Netherlands, July 29 QIAGEN N.V.,(Nasdaq: QGEN ) today announced ... will take place at 9:30 a.m. EDT on,Tuesday, August 5, and ... and Roland Sackers, Chief Financial Officer., What: ... When: 9:30 a.m. EDT on August ...
Cached Biology Technology:James C. Powell Joins Nerites Board of Directors 2Volcano Corporation Schedules Second Quarter Conference Call, Webcast 2Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) Second Quarter 2008 Financial Results Call Set for August 5 2
(Date:5/18/2013)... presented today at Digestive Disease Week (DDW) explores new ... impact of coffee on autoimmune disease and palliative care ... has been associated with reduced risk of fibrosis, a ... of java each month also correlate with lower risk ... Mayo Clinic, Rochester, MN, linked coffee consumption with reduced ...
(Date:5/17/2013)... (May 18, 2013) The AGA Research Foundation announced ... the relationship between the gut microbiota, one of today,s ... disease. , The AGA Research Awards Panel selected ... Massachusetts General Hospital and Harvard Medical School, Boston, as ... Dr. Chan will receive $25,000 of funding, commencing in ...
(Date:5/17/2013)... ages will celebrate the science and technology of ... lives during the inaugural Atlanta Science Festival, March ... local museums, corporations, K-12 schools and universities, the ... for children and adults at venues across the ... , The annual Atlanta Science Festival is a ...
Breaking Biology News(10 mins):Coffee consumption associated with reduced risk of autoimmune liver disease 2New gut microbiome research to explore red meat -- colorectal cancer pathway 2First Atlanta Science Festival set for 2014 2
... that the primary bacteria behind tuberculosis can grow ... these bacterial communities, the research team recently reported ... a possible reason why human tuberculosis (TB) requires ... potential cause of the relapses that can nonetheless ...
... where fresh water is usually in very short supply but ... Journal of Global Environmental Issues , Peter van der Gaag ... hit on the idea of using the untapped energy from ... gypsum. Fresh water resources are scarce and will be ...
... On June 10, 2008 the scientific journal " Vaccine " ... Lab, Inc., demonstrating that a protein sequence important in neurodegenerative ... of vaccine adjuvants. The major component of every ... particular virus, bacteria or even cancer cells. Search for ...
Cached Biology News:Source of drug-tolerant tuberculosis possibly behind TB relapses, intensity of treatment 2Rocky water source 2A protein sequence associated with Huntington’s disease may become life-saving vaccine component 2
... serum is collected off the clot fasted non-Swiss Albino ... Available Anticoagulants: N-02: Citrate ... N-08: Potassium Oxalate N-10: EDTA (Na) ... N-07: CPD N-09: K3EDTA N-11: ...
Recombinant Mouse Wnt-3a...
Contains 100 positive controls for effective screening of HDAC inhibitors by fluorometric method....
... There are at least 20 structurally and ... the TGF-beta superfamily. BMPs were originally identified ... formation. They are also involved in embryogenesis ... BMPs regulate the growth, differentiation, chemotaxis and ...
Biology Products: